Secondary Logo

Journal Logo

August 2014 - Volume 36 - Issue 6
pp: 413-502,e335-e402





A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL): A Report From the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium

Raetz, Elizabeth A.; Morrison, Debra; Romanos-Sirakis, Eleny; More

Journal of Pediatric Hematology/Oncology. 36(6):458-463, August 2014.

Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia

Patel, Sachit A.; Coulter, Don W.; Grovas, Alfred C.; More

Journal of Pediatric Hematology/Oncology. 36(6):491-494, August 2014.



In Reply

Duffner, Patricia K.; Armstrong, Floyd Daniel; Helton, Kathleen; More

Journal of Pediatric Hematology/Oncology. 36(6):501-502, August 2014.


Original Articles


Pathologic Risk-based Adjuvant Chemotherapy for Unilateral Retinoblastoma Following Enucleation

Sullivan, Erin M.; Wilson, Matthew W.; Billups, Catherine A.; More

Journal of Pediatric Hematology/Oncology. 36(6):e335-e340, August 2014.

Characterization of Localized Osteosarcoma of the Extremity in Children, Adolescents, and Young Adults From a Single Institution in South Texas

Sugalski, Aaron J.; Jiwani, Alisha; Ketchum, Norma S.; More

Journal of Pediatric Hematology/Oncology. 36(6):e353-e358, August 2014.

Monoallelic Mutations of the Perforin Gene may Represent a Predisposing Factor to Childhood Anaplastic Large Cell Lymphoma

Ciambotti, Benedetta; Mussolin, Lara; d’Amore, Emanuele S.G.; More

Journal of Pediatric Hematology/Oncology. 36(6):e359-e365, August 2014.

Morphology Corner


Clinical and Laboratory Observations


Show: